RGS 0.00% 12.0¢ regeneus ltd

News: Regeneus forms stem cell manufacturing partnership with Cryosite

  1. The collaboration agreement on the development and manufacture of new stem cell products includes fast-tracking production of Regeneus’ Progenza human osteoarthritis stem cell treatment for preclinical and clinical trials that will enable market entry into Japan.

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.